-
-
-
-
-
We do this occasionally, but we use plasma instead of saline. We use the formula mentioned above. We use RBCs diluted to a specific hematocrit when we have a patient who does not have the blood volume to safely prime an apheresis or dialysis circuit.
-
-
-
-
-
Maybe you could make a Product Group for it. I did that with Octaplas.
-
I would not use an enzyme treated screen as my only method for exactly that reason.
-
-
-
-
-
The answers are given at the end of each case study.
-
-
Are there still two ranges: one for storage and another for transport? I've always thought that was ludicrous.
-
Aliquots will warm even quicker than that due to their smaller mass.
-
The Pediatric Trauma Society used to have some examples on their website. I'm not a member any longer, so I can' check to see if they are still there. https://pediatrictraumasociety.org/
-
They may have developed their own system by now, but they used to market Blood Track.
-
-
-
We send both syringes and bags through the tube system. We have a special cap that we use for syringes for which it is obvious if someone has taken it off. That is to prevent partially used syringes from being accepted back into stock. That was an issue for all syringes, not just the ones sent through the tube.
-
-
-
I don't know what the titer is for incompatible kidney transplant, but for hearts they prefer less than 1:4, but there are other criteria as well. If the patient is less than 12 months old, they don't worry as much about the titer. I think they won't consider a patient who is over 2 years old. Again though, that is for hearts.
-
That's still a significant number of A subgroup kidneys to give B patients. Patients who are type B and need a kidney transplant usually have to wait years, and sometimes die because no type B kidney is available.
-
That is, in large part, why we HAVE different methods.
-
-
Dr. Jones?
-
-
I could not agree more. I believe that, if unchecked, some of the accrediting agencies will eventually regulate themselves into irrelevance.
